On hyperfibrinolysis and its treatment.
D000328:Adult; D000818:Animals; D000933:Antifibrinolytic Agents / Q000008:administration & dosage* / Q000097:blood; D001778:Blood Coagulation Disorders / Q000188:drug therapy / Q000209:etiology; D001792:Blood Platelets; D002449:Cell Aggregation; D004844:Epistaxis / Q000209:etiology; D005260:Female; D005333:Fetus / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism; D005342:Fibrinolysis; D006474:Hemorrhagic Disorders / Q000188:drug therapy* / Q000209:etiology; D006487:Hemostasis; D006801:Humans; D000860:Hypoxia / Q000378:metabolism; D007231:Infant, Newborn; D007962:Leukocytes / Q000201:enzymology; D008107:Liver Diseases / Q000188:drug therapy; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy; D011817:Rabbits
D000933:Antifibrinolytic Agents; D005341:Fibrinolysin